Title: "Molecular insights into epithelioid sarcoma"

Supervisor: dr.ssa R. Maestro

Publications:

• Andreuzzi, E., Capuano, A., Poletto, E., Pivetta, E., Fejza, A., Favero, A., Doliana, R., Cannizzaro, R., Spessotto, P., Mongiat, M., 2020a. Role of Extracellular Matrix in Gastrointestinal Cancer-Associated Angiogenesis. IJMS 21, 3686. 
• Andreuzzi, E., Fejza, A., Capuano, A., Poletto, E., Pivetta, E., Doliana, R., Pellicani, R., Favero, A., Maiero, S., Fornasarig, M., Cannizzaro, R., Iozzo, R.V., Spessotto, P., Mongiat, M., 2020b. Deregulated expression of Elastin Microfibril Interfacer 2 (EMILIN2) in gastric cancer affects tumor growth and angiogenesis. Matrix Biology Plus 6–7, 100029. 
• Capuano, A., Andreuzzi, E., Pivetta, E., Doliana, R., Favero, A., Canzonieri, V., Maiero, S., Fornasarig, M., Magris, R., Cannizzaro, R., Mongiat, M., Spessotto, P., 2019a. The Probe Based Confocal Laser Endomicroscopy (pCLE) in Locally Advanced Gastric Cancer: A Powerful Technique for Real–Time Analysis of Vasculature. Front. Oncol. 9, 513. 
• Capuano, A., Pivetta, E., Sartori, G., Bosisio, G., Favero, A., Cover, E., Andreuzzi, E., Colombatti, A., Cannizzaro, R., Scanziani, E., Minoli, L., Bucciotti, F., Amor Lopez, A.I., Gaspardo, K., Doliana, R., Mongiat, M., Spessotto, P., 2019b. Abrogation of EMILIN1-β1 integrin interaction promotes experimental colitis and colon carcinogenesis. Matrix Biology 83, 97– 115. 
• Casagrande, N., Borghese, C., Favero, A., Vicenzetto, C., Aldinucci, D., 2021. Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma. Cancer Letters 500, 182–193. 
• Citron, F., Segatto, I., Musco, L., Pellarin, I., Rampioni Vinciguerra, G.L., Franchin, G., Fanetti, G., Miccichè, F., Giacomarra, V., Lupato, V., Favero, A., Concina, I., Srinivasan, S., Avanzo, M., Castiglioni, I., Barzan, L., Sulfaro, S., Petrone, G., Viale, A., Draetta, G.F., Vecchione, A., Belletti, B., Baldassarre, G., 2021. miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC. EMBO Mol Med 13. 
• Favero, A., Segatto, I., Perin, T., Belletti, B., 2021. The many facets of MIR ‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response. WIREs RNA 12. 
• Rampioni Vinciguerra, G.L., Dall’Acqua, A., Segatto, I., Mattevi, M.C., Russo, F., Favero, A., Cirombella, R., Mungo, G., Viotto, D., Karimbayli, J., Pesce, M., Vecchione, A., Belletti, B., Baldassarre, G., 2021. p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer. Cell Death Dis 12, 951.